Issued Patents All Time
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12139492 | Substituted pyrimidines for the targeted degradation of Bruton's tyrosine kinase | Xianyou Peng, Borui Kang, HongJoong Kim | 2024-11-12 |
| 12109510 | Methods of solvent removal at ambient temperatures—cryovap | Vladimir Kolesnichenko, Galina Goloverda, Igor Kolesnichenko | 2024-10-08 |
| 11708381 | Inhibitors of androgen receptor signaling | Jiawang Liu, Shilong Zheng, Shanchun GUO | 2023-07-25 |
| 11098053 | Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells | Amy Strong, Stephen M. Boue, Matthew E. Burow, Bruce Alan Bunnell, Quan Jiang +1 more | 2021-08-24 |
| 11046715 | Boronic derivatives of hydroxamates as anticancer agents | Shilong Zheng, Jiawang Liu, Qiu Zhong, Shanchun GUO | 2021-06-29 |
| 10112962 | Boron-based prodrug strategy for increased bioavailability and lower-dosage requirements for drug molecules containing at least one phenol (or aromatic hydroxyl) group | Qiu Zhong, Shilong Zheng | 2018-10-30 |
| 10017475 | Anti-vasculature and anti-tubulin combretastatin analogs for treatment of cancer | Shilong Zheng, Qiu Zhong, Qiang Zhang | 2018-07-10 |
| 9669004 | Daidzein analogs as treatment for cancer | Matthew E. Burow, Stephen M. Boue, Thomas E. Wiese, Quan Jiang | 2017-06-06 |
| 9650369 | Anti-migration and anti-invasion thiazole analogs for treatment of cellular proliferative disease | Quan Jiang, Qiu Zhong, Qiang Zhang, Shilong Zheng | 2017-05-16 |
| 9353132 | Boron-based 4-hydroxytamoxifen and endoxifen prodrugs as treatment for breast cancer | Shilong Zheng, Quan Jiang, Qiu Zhong, Qiang Zhang | 2016-05-31 |
| 8962679 | Daidzein analogs as treatment for cancer | Matthew E. Burow, Stephen M. Boue, Thomas E. Wiese, Quan Jiang | 2015-02-24 |